Oncology Index

Leverage Industry-Leading Oncology Market Research

Stay Ahead of Oncology Market Access Trends

What Our Clients Are Saying

How We Can Help

We deliver quarterly reports that spotlight the latest and emerging access restrictions across targeted oncology therapeutic areas. These comprehensive insights help your team refine both national and regional strategies, transforming directional trends into practical, actionable steps for enhanced market performance.

How can the Oncology Index help my team understand payer behavior and coverage decisions in oncology?

The Oncology Index gives your team clear visibility into how payers manage oncology therapies by revealing coverage policies, restrictions, and decision-making patterns across plans.

The Oncology Index uncovers evolving oncology market dynamics by tracking shifts in coverage, site-of-care preferences, and management of new and emerging therapies.

How can the Oncology Index help inform oncology market access and commercial strategy?

By translating payer behavior and coverage insights into actionable intelligence, the Oncology Index helps inform smarter market access and commercial strategies.

Key Insights From MMIT

Access Trends for Innovative Technology Cell and Gene Therapies, Biomarkers, and Telemedicine

Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.

ACCESS THE RESOURCE
Stay In Touch

Be the first to know about new arrivals and promotions

Best Practices in Market Access